Stock vs Stock Comparison

Alkermes plc vs Johnson & Johnson

ALKS wins the Tale of the Tape 5–4.

ALKS
JNJ$223.24

🏆 Tale of the Tape

54
ALKSJNJ
16.4%Profitability (Net Margin)28.5%
20.8xValuation (P/E)26.1x
12.3%Efficiency (ROIC)18.3%
5/9Health (Piotroski F)4/9
5.7Safety (Altman Z)4.0
-5.3%Growth (Rev YoY)6.0%
Risk (Sharpe 1Y)2.69
0.37xBalance Sheet (D/E)1.44x
10.53%FCF Yield3.25%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricALKSJNJ
Market Cap$5.0B$542.4B
P/E Ratio20.8x26.1x
Forward P/E14.9x17.7x
P/B2.70x6.68x
Dividend Yield2.38%
Beta0.490.26

Quantitative Metrics

MetricALKSJNJ
DCF Fair Value$70.29$134.24
DCF Upside-43.6%
Piotroski F5/94/9
Altman Z5.703.97
Beneish M-3.30-2.27
FCF Yield10.53%3.25%
Net Debt/EBITDA0.5x
ROIC12.3%18.3%
WACC7.7%
ROIC – WACC10.5pp
Gross Margin86.7%67.9%
Net Margin16.4%28.5%
Rev Growth YoY-5.3%6.0%
Sharpe (1Y)2.69
Max Drawdown 3Y-16.0%
FCF Payout Ratio64%

ALKS Price

Loading chart...

JNJ Price

Loading chart...

ETF Exposure

ALKS found in:

XBI1.54%
SLYG0.73%
VFQY0.52%
SPSM0.36%
VBK0.17%
VTWO0.16%
VHT0.09%
VB0.07%
VXF0.07%
VFVA0.06%
SPTM0.01%

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ALKS vs JNJ: Head-to-Head Analysis

Alkermes plc (ALKS) and Johnson & Johnson (JNJ) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ALKS leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ALKS generates a return on invested capital (ROIC) of 12.3% compared to JNJ's 18.3%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

ALKS appears in 11 ETFs tracked by SecuritiesDB, while JNJ appears in 39 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ALKS or JNJ?

Our quantitative analysis compares ALKS and JNJ across nine fundamental dimensions. ALKS wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ALKS and JNJ correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.